Bentham Science Logo

Track Your Manuscript:


Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

Volume 20, 18 Issues, 2020
ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)
This journal supports open access
Order Your Article Before Print

Ranking and Category

  • 39th of 61 in

    Chemistry, Medicinal

  • 172nd of 229 in

    Oncology

In the current Pandemic scenario, all articles related to Coronavirus will be processed on a free, quick track basis, to ensure timely review and publication of much needed research

Meet the Executive Guest Editor(s)

H. Abrahamse
University of Johannesburg
Johannesburg
(South Africa)
Prof. Abrahamse is presently serving as a Director in the Laser Research Center. She has been awarded a degree of PhD in Molecular Biology/Biochemistry from Wits University. Her research interests include photobiology and photochemistry with specific reference to photodynamic cancer therapy, nanotechnology and targeted cancer therapy investigating the intricate mechanisms underlying cancer cell death induced by novel photochemotherapeutic compounds in conjunction with the use of nanoparticles. Her international standing as a researcher of distinction is supported by the fact that she has hosted 3 international conferences and has been invited to present her research at several international conferences. Her publication record is impressive with 154 peer-reviewed accredited journal publications, 19 chapters and 3 books, and a Scopus H-index of 27.


A. Ahmadi
Mazandaran University of Medical Sciences
Sari
(Iran)
Dr. Ahmadi is an experienced researcher with a demonstrated history of researching in the field of pharmaceutical sciences. He is skilled in clinical research, Animal models, Cellular models, Scientific writing & publishing. His research interest focuses on extensive fields of Pharmacology & Toxicology, Natural products, Radiopharmaceuticals, Nanomedicine, Radiation biology, Cancer chemoradiotherapy and other fields of Pharmacy at the Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. He has published many original and review articles in high-quality journals and selected as a recognized international editor and peer reviewer by famous publishers. In 2019, Dr. Amirhossein Ahmadi was placed in the top 1% of reviewers in Cross-Field on Publons global reviewer database.


A.M. Al-Abd
Gulf Medical University
Ajman
(United Arab Emirates)
Dr. Al-Abd has been promoted in the fields of research/academia from research assistant to associate research professor at the National Research Centre of Egypt. He worked for 6 years as an Assistant/Associate Professor at King Abdul-Aziz University and supervised the research activities within the Tissue Culture facility in the Faculty of Pharmacy, King Abdul-Aziz University. He is currently an Associate Professor of Pharmaceutical Sciences at the Gulf Medical University, United Arab Emirates. In addition to his title, he is a visiting scholar in Bouvé College of Health Sciences, Northeastern University, USA.


D. Corina
University of Medicine and Pharmacy "Victor Babes"
Timisoara
(Romania)
Dr. DANCIU CORINA is a Researcher, Pharmacist and the Head of Department of Pharmacognosy in Victor Babes University of Medicine and Pharmacy Timisoara. She has been awarded a degree of PhD in 2013. She has contributed her valuable 60 publications in different scientific journals. She is also a member of the editorial board of 6 international journals and co-author of patents. Her research interests include: quantitative and qualitative characterization of vegetal extracts, in vitro and in vivo evaluation of pure natural compounds or total extracts for different types of cancer, anti-inflammatory, antioxidant and antibacterial effect.


I.H. Eissa
Al-Azhar University
Cairo
(Egypt)
Ibrahim Hassan Eissa received his B.Sc. in 2003, Master’s degree in Medicinal Chemistry in 2009 and a PhD degree in 2012, both from the Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt. Since 2017, he has been an Associate Professor of Medicinal Chemistry at the Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy, Al-Azhar University and was made a manager of QAU in 2018. His scientific activity is focused on design, molecular modelling studies and synthesis of new bioactive compounds with potential anticancer activity against EGFR, VEGFR-2, Topoisomerases, tubulins, Carbonic anhydrases, and thymidylate synthase.


J. Fang
Nanjing University of Science and Technology
Nanjing
(China)
Dr. Jingkun Fang received both his B.Sc. and Ph.D. degrees from Hunan University in 2005 and 2010 respectively. During his Ph.D. period, he studied at the Okayama University of Science for 2 years under a joint Ph.D. program. After working in Changsha Research Institute of Mining and Metallurgy for nearly 3 years (2010-2013), he got a position as an associate professor at the Department of Chemistry in Nanjing University of Science and Technology (2013-present). He visited the Australian National University as a visiting scholar for 3 months in 2017. His research interests mainly focus on Organic Synthesis, Medicinal Chemistry, and Organic Functional Molecule.


J. Kim
Kangwon National University
Chuncheon-si
(South Korea)
Prof. Jin-Chul Kim did his Ph.D. in Chemical Engineering from KAIST. In academic career, he spent more than 15 years in the College of Biomedical Science, Kangwon National University. His research interests include drug delivery systems, colloid & interface science, and polymer science developed to minimize the side effects of drugs and to maximize their efficacy. His researches are focused on the development of efficacious drug carriers, mostly working on carriers that release their contents in response to stimuli such as light, temperature, pH, current flow, magnetic field, and some specific substances. His publication record is impressive with more than 240 SCI-grade papers as the corresponding author.


M. Lin
Taizhou People’s Hospital
Jiangsu
(China)
Dr Mei Lin is a Professor of Medical Science and holds a Doctor of Philosophy in Medicine. Her main research areas are nanomedicine, personalized diagnosis and therapy for cancer and tumour molecular imaging. Prof. Mei Lin is the academic leader of Jiangsu Key Clinical Specialty, the clinical laboratory of Taizhou People’s Hospital Affiliated to Nantong University. Her research work focuses on synthesis and characterization of Nano-drug and molecular probe, tumour molecular imaging, drug delivery, targeted therapy for cancer including chemotherapy, gene-therapy, magnetic thermotherapy and nuclide therapy.


T.S. Morais
University of Lisbon
Lisbon
(Portugal)
Dr. Tânia Morais has been awarded a degree of PhD in Inorganic Chemistry in 2013 from the University of Lisbon. She was honored by the Portuguese Chemical Society in 2014 with the prize “Portuguese Young Chemist Award”. Currently, she is a researcher at Centro de Química Estrutural(CQE) at Faculdade de Ciências da Universidade de Lisboa (FCUL). Her research focuses on the design, synthesis and characterization of Ru, Fe and Cu complexes with targeting molecules (e.g. peptides, carbohydrates, and biomolecules) in their structure for the selective inhibition of the cancer development and metastases. She has 23 papers published in international journals, 3 book chapters and 3 patents.


P. Poltronieri
Institute of Sciences of Food Productions, CNR-ISPA
Bari
(Italy)
Dr. Palmiro Poltronieri is presently serving as a researcher at the Agrofood Department of the Italian National Research Council. He holds a Ph.D. in Molecular and Cellular Biology from Verona University. His research interests include abiotic and biotic stress response in model plants, in bioactives from plants with a beneficial effect on health, in food microbiology and in the application of biocontrol strains for plant health. He is the co-founder of Biotecgen, a Small Medium Enterprise and service company, involved in European projects, such as RIBOREG, NANOMYC, ABSTRESS, and TOMGEM. He is Associate Editor to BMC Research Notes and is editor-in-chief for Challenges, an MDPI journal. He has co-authored 76 publications in international journals, 35 book chapters, and 5 books.


O. TOKGÜN
Pamukkale University
Denizili
(Turkey)
Dr. Onur received his Ph.D. in Medical Biology and Genetics from the Pamukkale Institute of Medical Sciences in 2017. After completion of his degree he got the Assist. Prof. position in the Department of Medical Genetics at the University of Pamukkale, Denizli/TURKEY. His interests are focused on cancer genetics and biology. In particular his laboratory is currently working on understanding the role of exosomes in tumorgenesis. Dr. Tokgun has published several research papers in scientific journals


Y. Tutar
Cumhuriyet University
Sivas
(Turkey)
Prof. Yusuf TUTAR currently continues his research at the University of Health Sciences, Faculty of Pharmacy, Department of Basic Pharmaceutical Sciences, Division of Biochemistry- Mektebi Tıbbiye-i Sahane, Turkey. He is also the head of the Molecular Medicine Program. He received his M.Sc. and Ph.D. at Oregon State University and Texas Tech University, respectively. He pursued his postdoctoral study at the National Institutes of Health (NIH/NIDDK), USA. His research focuses on Biochemistry, Biophysics, Genetics, and Molecular Biology with specialization in the fields of drug design, protein structure-function, protein folding, prion, microRNA, pseudogenes, molecular cancer, epigenetics, metabolites, proteomics, genomics, protein expression and characterization by spectroscopic and calorimetric methods.


Q. Yan
Zhejiang University
Zhejiang
(China)
Qiang Yan is a medical doctor, master supervisor, adjunct professor and FACS, Chairman of Department of General Surgery at Zhejiang University Huzhou Hospital, Director of Department of Hepatopancreatic and Biliary Surgery and Department of Surgery Teaching and Research. He is a member of Committees of Biliary Surgeons, Department of Surgeons and Hepatobiliary Minimal of Non-invasive Surgery, Chinese Medical Doctor Association and many other academic associations. He is a Special Reviewer of Journals of Medicine, Oncotarget; Special Member of Editorial Committees of Chinese Journal of General Surgery, Liver Cancer and Chinese Journal of Clinicians, a participant of High Level Talents of Zhejiang Medicine and Zhejiang Province 151 Talents.


L. Yang
Affiliated Hospital of North Sichuan Medical College
Sichuan
(China)
Professor Lin Yang has received his B.S. in Clinical Medicine from Westchina Medical University in 1990, M.S. in Surgery from Tianjin Medical University in 2001,and M.D. in Imaging Medicine and Nuclear Medicine from Sichuan University in 2007, respectively. He was employed as a professor of Imaging Medicine and Nuclear Medicine at Affiliated Hospital of North Sichuan Medical College in 2012. Professor Lin Yang published about 80 journal manuscripts, and seven academic books, respectively. He served as the Member of Cardiovascular and Interventional Radiological Society of Europe (CIRSE), and Chinese Society of Interventional Oncology; Deputy chairman of Sichuan Society of Interventional Medicine, and Reviewers of J Vasc Interv Radiol, WJG, and Clinics, respectively.


Editor-in-Chief

Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
ICCF-CNRS UMR 6296
Université Clermont Auvergne
Clermont-Ferrand
(France)

Biography View Full Editorial Board

Journal History

Current Medicinal Chemistry - Anti-Cancer Agents was launched in 2001 and later renamed in 2006 as Anti-Cancer Agents in Medicinal Chemistry.

Related Journals

Related eBooks

eBooks Catalog